Gene expression profile following stable expression of the cellular prion protein

Cellular and Molecular Neurobiology

Volumn 24, Issue 6, 2004, Pages 793-814

  Satoh, Jun Ichi ^a   Yamamura, Takashi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

CDR34; Cellular prion protein; Complement; Extracellular matrix; Microarray; Neurodegeneration; PPP2R2B

Indexed keywords

CELL PROTEIN; COMPLEMENT; PHOSPHOPROTEIN PHOSPHATASE 2A; PRION PROTEIN; SCLEROPROTEIN;

ARTICLE; CELL FUNCTION; CELL LINE; CELLULAR DISTRIBUTION; CEREBELLUM DEGENERATION; CONTROLLED STUDY; DNA MICROARRAY; EMBRYO; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RECOMBINATION; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL; NEUROPATHOLOGY; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PARANEOPLASTIC NEUROPATHY; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN SYNTHESIS; SPINOCEREBELLAR DEGENERATION; UPREGULATION;

CELL LINE; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRIONS; STEM CELLS;

ATAXIA; MUS MUSCULUS;

EID: 12944326897     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-004-6920-0     Document Type: Article

References (60)

1. Bendheim, P. E., Brown, H. R., Rudelli, R. D., Scala, L. J., Goller, N. L., Wen, G. Y., Kascsak, R. J., Cashman, N. R., and Bolton, D. C. (1992). Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42:149-156.
2. 3DHSP27). J. Biol. Chem. 276:26753-26761.
3. Berglund, E. O., Murai, K. K., Fredette, B., Sekerková, G., Marturano, B., Weber, L., Mugnaini, E., and Ranscht, B. (1999). Ataxia and abnormal cerebellar microorganization in mice with ablated contactin gene expression. Neuron 24:739-750.
4. Brown, D. R., Qin, K., Herms, J. W., Madlung, A., Manson, J., Strome, R., Fraser, P. E., Kruck, T., von Bohlen, A., Schulz-Schaeffer, W., Giese, A., Westaway, D., and Kretzschmar, H. (1997). The cellular prion protein binds copper in vivo. Nature 390:684-687.
5. Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S. J., Prusiner, S. B., Aguet, M., and Weissmann, C. (1992). Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-582.
6. Camby, I., Belot, N., Lefranc, F., Sadeghi, N., de Launoit, Y., Kaltner, H., Musette, S., Darro, F., Danguy, A., Salmon, I., Gabius, H.-J., and Kiss, R. (2002). Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J. Neuropathol. Exp. Neurol. 61:585-596.
7. Chen, Y.-T., Rettig, W., Yenamandra, A. K., Kozak, C. A., Chaganti, R. S. K., Poser, J. B., and Old, L. J. (1990). Cerebellar degeneration-related antigen: A highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. Proc. Natl. Acad. Sci. U.S.A. 87:3077-3081.
8. Chiarini, L. B., Freitas, A. R. O., Zanata, S. M., Brentani, R. R., Martins, V. R., and Linden, R. (2002). Cellular prion protein transduces neuroprotective signals. EMBO J. 21:3317-3326.
9. Collinge, J., Whittington, M. A., Sidle, K. C. L., Smith, C. J., Palmer, M. S., Clarke, A. R., and Jefferys, J. G. R. (1994). Prion protein is necessary for normal synaptic function. Nature 370:295-297.
10. DeArmond, S. J., Sánchez, H., Yehiely, F., Qiu, Y., Ninchak-Casey, A., Daggett, V., Camerino, A. P., Cayetano, J., Rogers, M., Groth, D., Torchia, M., Tremblay, P., Scott, M. R., Cohen, F. E., and Prusiner, S. B. (1997). Selective neuronal targeting in prion disease. Neuron 19:1337-1348.
11. Dimcheff, D. E., Portis, J. L., and Caughey, B. (2003). Prion proteins meet protein quality control. Trends Cell Biol. 13:337-340.
12. Finch, P. W., He, X., Kelley, M. J., Üren, A., Schaudies, R. P., Popescu, N. C., Rudikoff, S., Aaronson, S. A., Varmus, H. E., and Rubin, J. S. (1997). Purification and molecular cloning of a secreted, frizzled-related antagonist of Wnt action. Proc. Natl. Acad. Sci. U.S.A. 94:6770-6775.
13. Fujigasaki, H., Verma, I. C., Camuzat, A., Margolis, R. L., Zander, C., Lebre, A.-S., Jamot, L., Saxena, R., Anand, I., Holmes, S. E., Ross, C. A., Dürr, A., and Brice, A. (2001). SCA12 is a rare locus for autosomal dominant cerebellar ataxia: A study of an Indian family. Ann. Neurol. 49:117-121.
14. Graner, E., Mercadante, A. F., Zanata, S. M., Forlenza, O. V., Cabral, A. L. B., Veiga, S. S., Juliano, M. A., Roesler, R., Walz, R., Minetti, A., Izquierdo, I., Martins, V. R., and Brentani, R. R. (2000). Cellular prion protein binds laminin and mediates neuritogenesis. Mol. Brain Res. 76:85-92.
15. + currents in cerebellar Purkinje cells. Neurobiol. Dis. 8:324-330.
16. Holmes, S. E., O'Hearn, E. E., McInnis, M. G., Gorelick-Feldman, D. A., Kleiderlein, J. J., Callahan, C., Kwak, N. G., Ingersoll-Ashworth, R. G., Sherr, M., Sumner, A. J., Sharp, A. H., Ananth, U., Seltzer, W. K., Boss, M. A., Vieria-Saecker, A.-M., Epplen, J. T., Riess, O., Ross, C. A., and Margolis, R. L. (1999). Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nature Genet. 23:391-392.
17. Hosoda, K., Hammer, R. E., Richardson, J. A., Baynash, A. G., Cheung, J. C., Giaid, A., and Yanagisawa, M. (1994). Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79:1267-1276.
18. Hundt, C., Peyrin, J.-M., Haïk, S., Gauczynski, S., Leucht, C., Rieger, R., Riley, M. L., Deslys, J.-P., Dormont, D., Lasmézas, C. I., and Weiss, S. (2001). Identification of interaction domains of the prion protein with its 37-kDa/67-kda laminin receptor. EMBO J. 20:5876-5886.
19. Inagaki, N., Tsuura, Y., Namba, N., Masuda, K., Gonoi, T., Horie, M., Seino, Y., Mizuta, M., and Seino, S. (1995). Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J. Biol. Chem. 270:5691-5694.
20. A receptor responsiveness in cerebellar Purkinje neurons. J. Neurosci. 22:3969-3976.
21. Klein, M. A., Kaeser, P. S., Schwarz, P., Weyd, H., Xenarios, I., Zinnkernagel, R. M., Carroll, M. C., Verbeek, J. S., Botto, M., Walport, M. J., Molina, H., Kalinke, U., Acha-Orbea, H., and Aguzzi, A. (2001). Complement facilitates early prion pathogenesis. Nature Med. 7:488-492.
22. Koike, F., Satoh, J.-I., Miyake, S., Yamamoto, T., Kawai, M., Kikuchi, S., Nomura, K., Yokoyama, K., Ota, K., Kanda, T., Fukazawa, T., and Yamamura, T. (2003). Microarray analysis identifies interferon β-regulated genes in multiple sclerosis. J. Neuroimmunol. 139:109-118.
23. Kuwahara, C., Takeuchi, A. M., Nishimura, T., Haraguchi, K., Kubosaki, A., Matsumoto, Y., Saeki, K., Matsumoto, Y., Yokoyama, T., Itohara, S., and Onodera, T. (1999). Prions prevent neural cell-line death. Nature 400:225-226.
24. Lacroix, M., Ebel, C., Kardos, J., Dobó, J., Gál, P., Závodszky, P., Arlaud, G. J., and Thielens, N. M. (2001). Assembly and enzymatic properties of the catalytic domain of human complement protease C1r. J. Biol. Chem. 276:36233-36240.
25. Leclerc, P. C., Auger-Messier, M., Lanctot, P. M., Escher, E., Leduc, R., and Guillemette, G. (2002). A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling. Endocrinology 143:4702-4710.
26. Legname, G., Nelken, P., Guan, Z., Kanyo, Z. F., DeArmond, S. J., and Prusiner, S. B. (2002). Prion and doppel proteins bind to granule cells of the cerebellum. Proc. Natl. Acad. Sci. U.S.A. 99:16285-16290.
27. Mabbott, N. A., Bruce, M. E., Botto, M., Walport, M. J., and Pepys, M. B. (2001). Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nature Med. 7:485-487.
28. Ma, J., Wollmann, R., and Lindquist, S. (2002). Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298:1781-1785.
29. Manson, J. C., Clarke, A. R., Hooper, M. L., Aitchison, L., McConnell, I., and Hope, J. (1994). 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8:121-127.
30. Matsumoto, A., Naito, M., Itakura, H., Ikemoto, S., Asaoka, H., Hayakawa, I., Kanamori, H., Aburatani, H., Takaku, F., Suzuki, H., Kobari, Y., Miyai, T., Takahashi, K., Cohen, E. H., Wydro, R., Housman, D. E., and Kodama, T. (1990). Human macrophage scavenger receptors: Primary structure, expression, and localization in atherosclerotic lesions. Proc. Natl. Acad. Sci. U.S.A. 87:9133-9137.
31. Mbikay, M., Seidah, N. G., and Chrétien, M. (2001). Neuroendocrine secretory protein 7B2: Structure, expression and functions. Biochem. J. 357:329-342.
32. Millward, T. A., Zolnierowicz, S., and Hemmings, B. A. (1999). Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24:186-191.
33. Mironov, A., Jr., Latawiec, D., Wille, H., Bouzamondo-Bernstein, E., Legname, G., Williamson, R. A., Burton, D., DeArmond, S. J., Prusiner, S. B., and Peters, P. J. (2003). Cytosolic prion protein in neurons. J. Neurosci. 23:7183-7193.
34. Mitchell, S. A., Brown, E. C., Coldwell, M. J., Jackson, R. J., and Willis, A. E. (2001). Protein factor requirements of the Apaf-1 internal ribosome entry segment: Roles of polypyrimidine tract binding protein and upstream of N-ras. Mol. Cell. Biol. 21:3364-3374.
35. Moore, R. C., Lee, I. Y., Silverman, G. L., Harrison, P. M., Strome, R., Heinrich, C., Karunaratne, A., Pasternak, S. H., Chishti, M. A., Liang, Y., Mastrangelo, P., Wang, K., Smit, A. F. A., Katamine, S., Carlson, G. A., Cohen, F. E., Prusiner, S. B., Melton, D. W., Tremblay, P., Hood, L. E., and Westaway, D. (1999). Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292:797-817.
36. Moore, R. C., Mastrangelo, P., Bouzamondo, E., Heinrich, C., Legname, G., Prusiner, S. B., Hood, L., Westaway, D., DeArmond, S. J., and Tremblay, P. (2001). Doppl-induced cerebellar degeneration in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 98:15288-15293.
37. Nakashima, K., Yanagisawa, M., Arakawa, H., Kimura, N., Hisatsune, T., Kawabata, M., Miyazono, K., and Taga, T. (1999). Synergistic signaling in fetal brain by STAT3-smad1 complex bridged by p300. Science 284:479-482.
38. Okamoto, T., Schlegel, A., Scherer, P. E., and Lisanti, M. P. (1998). Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:5419-5422.
39. C triggers casapase 3 activation: Potentiation by proteasome inhibitors and blockade by anti-PrP antibodies. J. Neurochem. 83:1208-1214.
40. Perry, V. H., Cunningham, C., and Boche, D. (2002). Atypical inflammation in the central nervous system in prion disease. Curr. Opin. Neurol. 15:349-354.
41. Pfaff, S. L., Mendelsohn, M., Stewart, C. L., Edlund, T., and Jessel, T. M. (1996). Requirement for ILM homeobox gene Isl1 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation. Cell 84:309-320.
42. Prusiner, S. B. (1998). Prions. Proc. Natl. Acad. Sci. U.S.A 95:13363-13383.
43. Rachidi, W., Vilette, D., Guiraud,. P., Arlotto, M., Riondel, J., Laude, H., Lehmann, S., and Favier, A. (2003). Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J. Biol. Chem. 278:9064-9072.
44. Rossi, D., Cozzio, A., Flechsig, E., Klein, M. A., Rülicke, T., Aguzzi, A., and Weissmann, C. (2001). Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J. 20:694-702.
45. Sakaguchi, S., Katamine, S., Nishida, N., Moriuchi, R., Shigematsu, K., Sugimoto, T., Nakatani, A., Kataoka, Y., Houtani, T., Shirabe, S., Okada, H., Hasegawa, S., Miyamoto, T., and Noda, T. (1996). Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380:528-531.
46. Satoh, J.-I., and Kuroda, Y. (2000). Differential gene expression between human neurons and neuronal progenitor cells in culture: An analysis of arrayed cDNA clones in NTera2 human embryonal carcinoma cell line as a model system. J. Neurosci. Methods 94:155-164.
47. Satoh, J.-I., Kuroda, Y., and Katamine, S. (2000). Gene expression profile in prion protein-deficient fibroblasts in culture. Am. J. Pathol. 157:59-68.
48. Satoh, J.-I., Yukitake, M., Kurohara, K., Nishida, N., Katamine, S., Miyamoto, T., and Kuroda, Y. (1998). Cultured skin fibroblasts isolated from mice devoid of the prion protein gene express major heat shock proteins in response to heat stress. Exp. Neurol. 151:105-115.
49. Schmidt, K., Kins, S., Schild, A., Nitsch, R. M., Hemmings, B. A., and Götz, J. (2002). Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A. Eur. J. Neurosci. 16:2039-2048.
50. Schmitt-Ulms, G., Legname, G., Baldwin, M. A., Ball, H. L., Bradon, N., Bosque, P. J., Crossin, K. L., Edelman, G. M., DeArmond, S. J., Cohen, F. E., and Prusiner, S. B. (2001). Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J. Mol. Biol. 314:1209-1225.
51. Shmakov, A. N., McLennan, N. F., McBride, P., Farqyhar, C. F., Bode, J., Pennison, K. A., and Ghosh, S. (2000). Cellular prion protein is expressed in the human enteric nervous system. Nature Med. 6:840-841.
52. Simmons, A. D., Püschel, A. W., McPherson, J. D., Overhauser, J., and Lovett, M. (1998). Molecular cloning and mapping of human semaphorin F from the Cri-du-chat candidate interval. Biochem. Biophys. Res. Commun. 242:685-691.
53. Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., and Williams, B. R. G. (2003). Activation of the interferon system by short-interfering RNAs. Nature Cell Biol. 5:834-839.
54. Sontag, E., Nunbhakdi-Craig, V., Lee, G., Brandt, R., Kamibayashi, C., Kuret, J., White, C. L., III, Mumby, M. C., and Bloom, G. S. (1999). Molecular interactions among protein phosphatase 2A, tau, and microtubules. J. Biol. Chem. 274:25490-25498.
55. Tezak, Z., Prandini, P., Boscaro, M., Marin, A., Devaney, J., Marino, M., Fanin, M., Trevisan, C. P., Park, J., Tyson, W., Finkel, R., Garcia, C., Angelini, C., Hoffman, E. P., and Pegoraro, E. (2003). Clinical and molecular study in congenital muscular dystrophy with partial laminin α2 (LAMA2) deficiency. Hum. Mut. 21:103-111.
56. Tobler, I., Gaus, S. E., Deboer, T., Achermann, P., Fischer, M., Rülicke, T., Moser, M., Oesch, B., McBride, P. A., and Manson, J. C. (1996). Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380:639-642.
57. Vey, M., Pilkuhn, S., Wille, H., Nixon, R., DeArmond, S. J., Smart, E. J., Anderson, R. G. W., Taraboulos, A., and Prusiner, S. B. (1996). Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc. Natl. Acad. Sci. U.S.A. 93:14945-14949.
58. Wang, X.-Y., Smith, D. I., Liu, W., and James, C. D. (1998). GBAS, a novel gene encoding a protein with tyrosine phosphorylation sites and a transmembrane domain is co-purified with EGFR. Genomics 49:448-451.
59. Westaway, D., DeArmond, S. J., Cayetano-Canlas, J., Groth, D., Foster, D., Yang, S. L., Torchia, M., Carlson, G. A., and Prusiner, S. B. (1994). Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76:117-129.
60. Yamaguchi, T., Murata, Y., Fujiyoshi, Y., and Doi, T. (2003). Regulated interaction of endothelin B receptor with caveolin-1. Eur. J. Biochem. 270:1816-1827.